Dipyridamole increases human red blood cell deformability. 1992

A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
Institute of Biomedical Sciences, Terumo Shonan Centre, Kanagawa, Japan.

An automated filtration technique has been used to investigate the effect of dipyridamole (DP) on red blood cell deformability in patients identified as having rigid red cells. They were patients on haemodialysis (HD) for chronic renal failure (n = 18), patients with peripheral vascular disease (PVD, n = 23) and controls (hospital outpatients, n = 33). Leucocytes and platelets were removed from heparinised blood by filtration through Imugard wool. Washed red cell suspensions in buffer at 5% haematocrit, without or with 5 microM DP, were filtered through Nuclepore Hemafil Membranes with 4.7 microns pores. The initial steady state relative filtration pressure (iRFP) was used to assess cell deformability. A low iRFP value reflects increased deformability and vice versa. The mean iRFP values were 0.33, 0.393 and 0.403 for controls, PVD and HD patients respectively, indicating that the red cells in the two groups of patients were significantly more rigid. DP reduced the iRFP to 0.266, 0.278 and 0.263 for controls, PVD and HD patients respectively. The results suggest that DP may be beneficial when red cell rigidity contributes to impaired microvascular perfusion.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004907 Erythrocyte Deformability Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature. Erythrocyte Filterability,Deformability, Erythrocyte,Filterability, Erythrocyte
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
October 1983, British journal of clinical pharmacology,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
September 2016, Clinical hemorheology and microcirculation,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
February 1988, Archives of surgery (Chicago, Ill. : 1960),
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
December 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
January 2002, Blood cells, molecules & diseases,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
February 1998, American journal of respiratory and critical care medicine,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
November 1984, The American journal of physiology,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
February 1995, Arthritis and rheumatism,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
March 2022, Lab on a chip,
A R Saniabadi, and T C Fisher, and C S Lau, and A Bridges, and J Taylor, and J Belch, and C D Forbes
June 2014, Journal of biomechanics,
Copied contents to your clipboard!